latest news releases from the newsroom
Guaranty Federal Bancshares, Inc.
Guaranty Federal Bancshares, Inc. Announces a 39 Percent Increase in Quarterly Earnings Per Share
SPRINGFIELD, Mo., Oct. 14, 2005 (PRIMEZONE) -- Guaranty Federal Bancshares, Inc., (Nasdaq:GFED), the holding company (the "Company") for Guaranty Bank, today announces the following highlights for its third quarter ended September 30, 2005:
TDC Divests Directories
COPENHAGEN, Denmark, Oct. 14, 2005 (PRIMEZONE) -- TDC to sell TDC Directories for DKK 4.85bnTDC A/S ("TDC") announced today that it has signed a definitive agreement to sell its fully owned subsidiary TDC Forlag A/S ("TDC Directories" or the "Company") to European Directories S.A. ("EDSA"), a consortium led by Macquarie Capital Alliance Group and the holding company of European Directories (formerly known as the YBR Group), for a total consideration of DKK 4.85bn on a cash and debt free basis. The cash proceeds will amount to approximately DKK 5.0bn, including the receipt of cash existing in the Company. The agreement is only subject to statutory merger control clearance, including clearance from Swedish and Austrian competition authorities, which are expected before the end of 2005.
The Davis Center
'Sound Is The Source' to Be Introduced at The Davis Center's Grand Opening
ROCKAWAY, N.J., Oct. 14, 2005 (PRIMEZONE) -- Sound Is The Source, a not for profit corporation supporting research projects related to the impact of sound on the body, will be introduced at the Grand Opening Celebration of The Davis Center on October 16, 2005 at One Mannino Drive, Rockaway, NJ. The Davis Center, the world's most comprehensive sound therapy center, has donated office space for the operation of Sound Is The Source.
Manhattan Pharmaceuticals, Inc.
Manhattan Pharmaceuticals to Present Preliminary Phase I Obesity Drug Data at 2005 Annual Meeting of NAASO
NEW YORK, Oct. 14, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) will present preliminary Phase I results of its obesity drug candidate, Oleoyl-estrone (OE), an experimental, orally administered small molecule in development for the treatment of obesity. The data will be shown in a poster presentation on Sunday, October 16th at the 2005 Annual Scientific Meeting of NAASO, The Obesity Society, in Vancouver, BC.
BILIA SELLING PROPERTY IN STOCKHOLM
Through a company transaction, Bilia has signed an agreement involving the sale
of a car dealership in Bredden in Stockholm.
This property has a total area of approximately 4,200 m2 and currently has no
tenants, as Bilia Personbilar (Cars) has transferred its operations to the main
facility in Haga Norra.
Bilia’s capital gain on the sale of these shares is around SEK 6 M after tax.
The date on which possession of the property can take place is 29 November 2005.
Bilia has another prop
Invitation to Enea AB's Telephone Conference
TABY, Sweden, Oct. 14, 2005 (PRIMEZONE) -- Enea publishes the Interim Report for Quarter 3, 2005 on Tuesday, October 25, 2005 before the opening of the stock market. The same day, Enea invites you to a telephone conference at 14.30 am CET with CEO, Johan Wall and CFO, Hakan Gustavson.